Avenir Corp - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 70 filers reported holding ANTARES PHARMA INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Avenir Corp ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$1,242,000
+15.2%
302,852
+0.3%
0.10%
+19.3%
Q4 2021$1,078,000
-1.7%
301,852
+0.2%
0.08%
-9.8%
Q3 2021$1,097,000
-16.5%
301,2970.0%0.09%
-11.5%
Q2 2021$1,314,000
+6.1%
301,2970.0%0.10%
-2.8%
Q1 2021$1,238,000
+3.0%
301,2970.0%0.11%
-7.0%
Q4 2020$1,202,000
+56.9%
301,297
+6.2%
0.12%
+43.8%
Q3 2020$766,000
-1.8%
283,7970.0%0.08%
-10.1%
Q2 2020$780,000
+16.4%
283,7970.0%0.09%
-2.2%
Q1 2020$670,000
-49.7%
283,797
+0.2%
0.09%
-32.6%
Q4 2019$1,331,000
+39.1%
283,097
-1.0%
0.14%
+35.0%
Q3 2019$957,000
+1.7%
286,0970.0%0.10%
+2.0%
Q2 2019$941,000
+7.7%
286,097
-0.9%
0.10%
+5.4%
Q1 2019$874,000
+10.8%
288,597
-0.5%
0.09%
-6.1%
Q4 2018$789,000
-19.5%
290,097
-0.5%
0.10%
-8.3%
Q3 2018$980,000
+30.3%
291,5970.0%0.11%
+25.6%
Q2 2018$752,000
+17.1%
291,5970.0%0.09%
+22.9%
Q1 2018$642,000
+10.7%
291,5970.0%0.07%
+29.6%
Q4 2017$580,000
-49.1%
291,597
-17.1%
0.05%
-44.9%
Q3 2017$1,139,000
+0.6%
351,6850.0%0.10%
-2.0%
Q2 2017$1,132,000
+24.0%
351,685
+9.4%
0.10%
+25.0%
Q1 2017$913,000
+21.9%
321,5350.0%0.08%
+23.1%
Q4 2016$749,000
+38.7%
321,5350.0%0.06%
+38.3%
Q3 2016$540,000
+59.8%
321,5350.0%0.05%
+67.9%
Q2 2016$338,000
+20.7%
321,5350.0%0.03%
+16.7%
Q1 2016$280,000
-28.0%
321,5350.0%0.02%
-22.6%
Q4 2015$389,000
-28.9%
321,5350.0%0.03%
-32.6%
Q3 2015$547,000
-18.2%
321,5350.0%0.05%
-8.0%
Q2 2015$669,000
-23.7%
321,535
-0.6%
0.05%
-21.9%
Q1 2015$877,000
+8.8%
323,535
+3.2%
0.06%
+4.9%
Q4 2014$806,000
+30.0%
313,535
-7.4%
0.06%
+17.3%
Q3 2014$620,000
-31.9%
338,535
-0.7%
0.05%
-31.6%
Q2 2014$911,000
-23.2%
341,035
+0.7%
0.08%
-26.9%
Q1 2014$1,186,000
-21.3%
338,735
+0.5%
0.10%
-23.5%
Q4 2013$1,507,000
+33.8%
337,085
+21.5%
0.14%
+24.8%
Q3 2013$1,126,000
-2.4%
277,4600.0%0.11%
-9.2%
Q2 2013$1,154,000277,4600.12%
Other shareholders

There were no reported owners of ANTARES PHARMA INC in Q2 2016.

NameSharesValueWeighting ↓
View complete list of ANTARES PHARMA INC shareholders